Abstract

Background Integrase defective lentiviral vectors (IDLV) represent a promising delivery system for immunization purposes. Human dendritic cells (DC) are the main cell types mediating the immune response and are readily transduced by IDLV, allowing effective triggering of in vitro expansion of antigen-specific primed CD8+ T cells. However, DC transduction efficiency is hindered by the presence of SAMHD1 restriction factor, which inhibits viral DNA synthesis.

Highlights

  • Integrase defective lentiviral vectors (IDLV) represent a promising delivery system for immunization purposes

  • These results have important implications for the development of vaccine strategies based on the use of IDLV as a novel, safe and efficient delivery system

  • Monocytes from HLAA*0201 and M1-positive selected donors were differentiated into dendritic cells (DC) and transduced with IDLV-M1/Vpx and control IDLV/M1 or left untreated

Read more

Summary

Background

Integrase defective lentiviral vectors (IDLV) represent a promising delivery system for immunization purposes. DC transduction efficiency is hindered by the presence of SAMHD1 restriction factor, which inhibits viral DNA synthesis

Conclusion
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.